Answer
Yes. Hepatitis B reactivation has occurred with BCR-ABL inhibitors, so testing is required before treatment and carriers need specialist monitoring.
Sources for this answer
- UK GovernmentUK Government · Reputable Web
- Bosulif 100 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.